Evidence map›Paper›PMID 31659255›Full record

ArticleOncogene2020

Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.

Sospeter N Njeru, Johann Kraus, Jitendra K Meena, André Lechel, Sarah-Fee Katz, Mukesh Kumar, Uwe Knippschild, Anca Azoitei, Felix Wezel, Christian Bolenz and 8 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phytochemical analysis,Frontiers in pharmacology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Downregulation ofInternational journal of molecular sciences · 2020
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Sospeter N Njeru *Leibniz Institute on Aging, Fritz Lipmann Institute e.V., 07745, Jena, Germany.ORCID http://orcid.org/0000-0003-1154-0777
Johann Kraus *Institute of Medical Systems Biology, Ulm University, 89081, Ulm, Germany.
Jitendra K Meena *Leibniz Institute on Aging, Fritz Lipmann Institute e.V., 07745, Jena, Germany.ORCID http://orcid.org/0000-0003-0199-9357
André LechelDepartment of Internal Medicine I, Ulm University Hospital, 89081, Ulm, Germany.ORCID http://orcid.org/0000-0003-0221-6959
Sarah-Fee KatzDepartment of Internal Medicine I, Ulm University Hospital, 89081, Ulm, Germany.
Mukesh KumarDepartment of Urology, Ulm University Hospital, 89081, Ulm, Germany.
Uwe KnippschildDepartment of General and Visceral Surgery, Ulm University Hospital, 89081, Ulm, Germany.
Anca AzoiteiDepartment of Urology, Ulm University Hospital, 89081, Ulm, Germany.
Felix WezelDepartment of Urology, Ulm University Hospital, 89081, Ulm, Germany.
Christian BolenzDepartment of Urology, Ulm University Hospital, 89081, Ulm, Germany.
Frank LeithäuserInstitute of Pathology, Ulm University, 89075, Ulm, Germany.
André GollowitzerInstitute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Omid OmraniLeibniz Institute on Aging, Fritz Lipmann Institute e.V., 07745, Jena, Germany.
Christian HoischenLeibniz Institute on Aging, Fritz Lipmann Institute e.V., 07745, Jena, Germany.
Andreas KoeberleInstitute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.ORCID http://orcid.org/0000-0001-6269-5088
Hans A Kestler *Institute of Medical Systems Biology, Ulm University, 89081, Ulm, Germany. hans.kestler@uni-ulm.de.ORCID http://orcid.org/0000-0002-4759-5254
Cagatay Günes *Department of Urology, Ulm University Hospital, 89081, Ulm, Germany. cagatay.guenes@uniklinik-ulm.de.ORCID http://orcid.org/0000-0003-4301-2223
K Lenhard Rudolph *Leibniz Institute on Aging, Fritz Lipmann Institute e.V., 07745, Jena, Germany. lenhard.rudolph@leibniz-fli.de.
University Hospital Ulm · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEUniversität Ulm · DEBaylor College of Medicine · USFriedrich Schiller University Jena · DEUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aneuploidy can instigate tumorigenesis. However, mutations in genes that control chromosome segregation are rare in human tumors as these mutations reduce cell fitness. Screening experiments indicate that the knockdown of multiple classes of genes that are not directly involved in chromosome segregation can lead to aneuploidy induction. The possible contribution of these genes to cancer formation remains yet to be defined. Here we identified gene knockdowns that lead to an increase in aneuploidy in checkpoint-deficient human cancer cells. Computational analysis revealed that the identified genes overlap with recurrent mutations in human cancers. The knockdown of the three strongest selected candidate genes (ORP3, GJB3, and RXFP1) enhances the malignant transformation of human fibroblasts in culture. Furthermore, the knockout of Orp3 results in an aberrant expansion of lymphoid progenitor cells and a high penetrance formation of chromosomal instable, pauci-clonal B-cell lymphoma in aging mice. At pre-tumorous stages, lymphoid cells from the animals exhibit deregulated phospholipid metabolism and an aberrant induction of proliferation regulating pathways associating with increased aneuploidy in hematopoietic progenitor cells. Together, these results support the concept that aneuploidy-inducing gene deficiencies contribute to cellular transformation and carcinogenesis involving the deregulation of various molecular processes such as lipid metabolism, proliferation, and cell survival.

Indexed as

AneuploidyGene Knockdown TechniquesAnimalsCell Line, TumorCell Transformation, NeoplasticFatty Acid-Binding ProteinsFibroblastsHumansLymphoma, B-CellMiceOxysterol Binding ProteinsFatty Acid-Binding ProteinsOSBPL3 protein, humanOxysterol Binding Proteins

Identifiers

PMID31659255
OpenAlexW2981425072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.